Indefinite Delivery Contract HHSN261201000021I
- This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The $550,000 single-award contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase master contract and aims to procure tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. Under a $488,000 delivery order, Sloan-Kettering Institute for Cancer Research, a...
- This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract, valued at $236,000.00, is part of the NCI Cancer Genome Atlas (TCGA) Program and aims to procure tissue samples and data from various cancer types for the TCGA's comprehensive genomic characterization efforts. The contract was awarded in August...
- This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Indivumed, Inc. to provide tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. The contract has a total ceiling value of $2,712,155.00 and does not have a set-aside designation. The contract consists of three firm-fixed-price delivery orders with a combined total value of $2,259,118.07. The...
- This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to the British Columbia Cancer Agency Branch, a Canadian non-profit organization, to procure tissue samples and data from various cancer types to support the NCI's Cancer Genome Atlas (TCGA) program. The $16,000 firm fixed-price delivery order was issued on September 20, 2010 under the NCI Cancer Genome Atlas Program Tissue Purchase contract, which does not have a set-aside designation....
- This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to the Board of Regents of the University of Nebraska. The contract, valued at $37,000, supports the Cancer Genome Atlas (TCGA) program by providing tissue samples and data from various types of cancer. The University of Nebraska Medical Center (UNMC) is the prime contractor performing this work. Under the master NCI Cancer Genome Atlas Program Tissue Purchase contract, a $11,100 firm...
- This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The contract, valued at $200,000, supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The initial $120,500 task order under this contract requires the...
- This indefinite delivery contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to Duke University as the prime contractor. The contract has a ceiling value of $360,000 and supports the Cancer Genome Atlas (TCGA) program, which was funded under the American Recovery and Reinvestment Act (ARRA). Under this IDC, Duke University will provide tissue samples and data from various types of cancer to contribute to the TCGA program. The contract is a task order under the...
- This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The University of Texas MD Anderson Cancer Center (MD Anderson). The contract supports the collection of tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program, which aims to comprehensively characterize the genomic changes associated with different cancer types. As a leading cancer research institution, MD Anderson...
- This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of Texas MD Anderson Cancer Center (MD Anderson), a subcomponent of the University of Texas System. The contract is to provide tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program, which is funded through the American Recovery and Reinvestment Act (ARRA). The initial delivery order under this...
- This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The $178,230 firm fixed-price delivery order is for the recovery and delivery of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program, which is part of the agency's efforts to characterize the genomic changes in cancer....
- HHSN261201000021IIndefinite Delivery Contract
- 1Federal Contract Awards
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF) as the prime contractor. The contract, valued at $41,000, is for the delivery of tissue samples and data from various cancer types to support the Cancer Genome Atlas (TCGA) program, a collaborative effort to comprehensively map the genetic changes in various types of cancer. This contract is a delivery order under the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract and does not have a set-aside designation. The initial task order under this IDV, valued at $24,087.50, was also awarded to UCSF. This task order is for the delivery of tissue samples and data from various cancer types to support the TCGA program. As a leading academic medical center and research institution, UCSF has a strong track record of partnering with federal agencies like NIH to conduct cutting-edge biomedical research and deliver healthcare innovations. The contract's period of performance extends through September 30, 2014.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 4 | Other Administrative Action | $0 | 7/3/13 | |
| 3 | Other Administrative Action | $0 | 4/11/12 | |
| 2 | Other Administrative Action | $0 | 10/27/11 | |
| 1 | Other Administrative Action | $0 | 9/2/10 | |
| Not listed | Not listed | $0 | 4/20/10 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order HHSN261201000021I-HHSN26100001 | The Regents Of The University Of California. San Francisco | $24.1k | 4/21/10 | 9/30/14 | 12/29/14 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
RECOVERY - Tissue Purchase Order Contract Acquisitions for NCI's The Cancer Genome Atlas Program | RFQ-NCI-10006-AS | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 12/4/09, 8:31 AM |